I agree and understand.
But keep in mind, there is value in the underlying Intellectual Property and Patents.
It then becomes a matter of identifying the potential application of that IP and Patent.
I think the real opportunity for GTG at the moment is to get momentum with their Multi-test product and tap into government subsidised funding, as preventative medicine will save governments lots of money. So GTG management need to build better relationships and/or employ people with those established relationships.
Hopefully EasyDNA will also give them some more global visibility and opportunity for increased sales.
- Forums
- ASX - By Stock
- GTG
- News: GTG Genetic Technologies Announces New Partnership and geneType COVID-19 Risk Test Patent...
News: GTG Genetic Technologies Announces New Partnership and geneType COVID-19 Risk Test Patent..., page-4
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GTG (ASX) to my watchlist
|
|||||
Last
4.1¢ |
Change
-0.004(8.89%) |
Mkt cap ! $5.962M |
Open | High | Low | Value | Volume |
4.6¢ | 4.6¢ | 4.1¢ | $15.72K | 359.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 30580 | 4.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.5¢ | 22961 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 30580 | 0.041 |
3 | 82500 | 0.040 |
2 | 27780 | 0.036 |
1 | 130000 | 0.035 |
1 | 88000 | 0.034 |
Price($) | Vol. | No. |
---|---|---|
0.045 | 22961 | 1 |
0.046 | 139939 | 1 |
0.058 | 181125 | 2 |
0.059 | 73500 | 1 |
0.061 | 35590 | 1 |
Last trade - 12.44pm 05/08/2024 (20 minute delay) ? |
Featured News
GTG (ASX) Chart |